Cargando…

Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature

We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 8...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca-Johnson, Javier, Ninfea, Jose I. Ruades, Pearson, Lauren, Conant, Joanna, Bryant, Ronald, Zakai, Neil A., Tang, Mary E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056307/
https://www.ncbi.nlm.nih.gov/pubmed/27746819
http://dx.doi.org/10.1155/2016/8324791
_version_ 1782458871208476672
author De Luca-Johnson, Javier
Ninfea, Jose I. Ruades
Pearson, Lauren
Conant, Joanna
Bryant, Ronald
Zakai, Neil A.
Tang, Mary E.
author_facet De Luca-Johnson, Javier
Ninfea, Jose I. Ruades
Pearson, Lauren
Conant, Joanna
Bryant, Ronald
Zakai, Neil A.
Tang, Mary E.
author_sort De Luca-Johnson, Javier
collection PubMed
description We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy.
format Online
Article
Text
id pubmed-5056307
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50563072016-10-16 Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature De Luca-Johnson, Javier Ninfea, Jose I. Ruades Pearson, Lauren Conant, Joanna Bryant, Ronald Zakai, Neil A. Tang, Mary E. Case Rep Med Case Report We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy. Hindawi Publishing Corporation 2016 2016-09-26 /pmc/articles/PMC5056307/ /pubmed/27746819 http://dx.doi.org/10.1155/2016/8324791 Text en Copyright © 2016 Javier De Luca-Johnson et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
De Luca-Johnson, Javier
Ninfea, Jose I. Ruades
Pearson, Lauren
Conant, Joanna
Bryant, Ronald
Zakai, Neil A.
Tang, Mary E.
Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_full Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_fullStr Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_full_unstemmed Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_short Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_sort myeloid neoplasms with t(5;12) and etv6-acsl6 gene fusion, potential mimickers of myeloid neoplasm with pdgfrb rearrangement: case report with imatinib therapy and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056307/
https://www.ncbi.nlm.nih.gov/pubmed/27746819
http://dx.doi.org/10.1155/2016/8324791
work_keys_str_mv AT delucajohnsonjavier myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT ninfeajoseiruades myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT pearsonlauren myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT conantjoanna myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT bryantronald myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT zakaineila myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT tangmarye myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature